Use of Conditionally Active Ras Fusion Proteins to Study Epidermal Growth, Differentiation, and Neoplasia

Methods in Enzymology

Volumn 407, Issue , 2006, Pages 691-702

  Reuter, Jason A ^a   Khavari, Paul A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HYBRID PROTEIN; RAS FUSION PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; EPIDERMIS; GENE ACTIVATION; GENE ACTIVITY; HUMAN; KERATINOCYTE; NEOPLASM; PRIORITY JOURNAL; REVIEW;

EID: 33744537015     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)07054-0     Document Type: Review

References (25)

1. Berthois Y., Katzenellenbogen J.A., and Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 83 (1986) 2496-2500
2. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., and Der C.J. Increasing complexity of Ras signaling. Oncogene 17 (1998) 1395-1413
3. Choate K.A., Kinsella T.M., Williams M.L., Nolan G.P., and Khavari P.A. Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum. Gene Ther. 7 (1996) 2247-2253
4. Dajee M., Lazarov M., Zhang J.Y., Cai T., Green C.L., Russell A.J., Marinkovich M.P., Tao S., Lin Q., Kubo Y., and Khavari P.A. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421 (2003) 639-643
5. Dajee M., Tarutani M., Deng H., Cai T., and Khavari P.A. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene 21 (2002) 1527-1538
6. de Rooij J., and Bos J.L. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14 (1997) 623-625
7. Deng H., Choate K.A., Lin Q., and Khavari P.A. High-efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques 25 (1998) 274-280
8. Eilers M., Picard D., Yamamoto K.R., and Bishop J.M. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340 (1989) 66-68
9. Ewen M.E. Relationship between Ras pathways and cell cycle control. Prog. Cell Cycle Res. 4 (2000) 1-17
10. Kinsella T.M., and Nolan G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7 (1996) 1405-1413
11. Lazarov M., Green C.L., Zhang J.Y., Kubo Y., Dajee M., and Khavari P.A. Escaping G1 restraints on neoplasia-Cdk4 regulation by Ras and NF-kappa B. Cell Cycle 2 (2003) 79-80
12. Lin A.W., and Lowe S.W. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl. Acad. Sci. USA 98 (2001) 5025-5030
13. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., and Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23 (1995) 1686-1690
14. Mainiero F., Murgia C., Wary K.K., Curatola A.M., Pepe A., Blumemberg M., Westwick J.K., Der C.J., and Giancotti F.G. The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J. 16 (1997) 2365-2375
15. McCarthy S.A., Samuels M.L., Pritchard C.A., Abraham J.A., and McMahon M. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9 (1995) 1953-1964
16. Metzger D., and Chambon P. Site- and time-specific gene targeting in the mouse. Methods 24 (2001) 71-80
17. Mirza A.M., Kohn A.D., Roth R.A., and McMahon M. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ. 11 (2000) 279-292
18. Picard D., Salser S.J., and Yamamoto K.R. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54 (1988) 1073-1080
19. Picard D. Regulation of protein function through expression of chimaeric proteins. Curr. Op. Biotech. 5 (1994) 511-515
20. Roper E., Weinberg W., Watt F.M., and Land H. p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep. 2 (2001) 145-150
21. Samuels M.L., Weber M.J., Bishop J.M., and McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13 (1993) 6241-6252
22. Sewing A., Wiseman B., Lloyd A.C., and Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17 (1997) 5588-5597
23. Shields J.M., Pruitt K., McFall A., Shaub A., and Der C.J. Understanding Ras: 'It ain't over 'til it's over'. Trends Cell Biol. 10 (2000) 147-154
24. Tarutani M., Cai T., Dajee M., and Khavari P.A. Inducible activation of Ras and Raf in adult epidermis. Cancer Res. 63 (2003) 319-323
25. Zhu A.J., Haase I., and Watt F.M. Signaling via beta1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. Proc. Natl. Acad. Sci. USA 96 (1999) 6728-6733